Skip to main content
logo
Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada flag Canada · Delayed Price · Currency is CAD
0.1000
0.00 (0.00%)
Oct 9, 2026, 3:46 PM EST

Rapid Dose Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Mar - Feb.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Market Capitalization
14202221926
Market Cap Growth
-40.74%-7.92%6.81%121.17%-64.76%56.16%
Enterprise Value
202625231128
Last Close Price
0.100.150.170.170.090.26

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
PS Ratio
5.357.3110.5620.2012.9815.10
PB Ratio
-1.83-2.83-4.23-6.53-3.49105.16
P/TBV Ratio
-----105.16

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
EV/Sales Ratio
7.609.5311.7923.0015.7515.81

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Debt / Equity Ratio
-0.77-0.74-0.50-0.78-0.795.70
Net Debt / Equity Ratio
-0.77-0.74-0.50-0.73-0.785.56
Net Debt / EBITDA Ratio
-3.18-2.65-0.65-0.83-0.65-0.37
Net Debt / FCF Ratio
27.49-19.57-2.25-1.00-2.43-0.46
Asset Turnover
0.721.131.190.490.270.51
Inventory Turnover
6.096.784.252.791.671.26
Quick Ratio
0.020.020.050.130.040.09
Current Ratio
0.040.040.100.230.090.25
Return on Assets (ROA)
-33.30%-55.19%-148.14%-93.37%-83.34%-77.93%
Return on Capital Employed (ROCE)
33.90%42.10%80.10%298.70%134.20%-698.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Earnings Yield
-23.00%-16.72%-24.54%-20.89%-40.87%-32.08%
FCF Yield
1.53%-1.34%-5.23%-11.13%-9.27%-11.49%
Buyback Yield / Dilution
-5.68%-6.73%-18.68%-1.50%-3.19%-28.83%